Infinity Pharmaceuticals | INFI - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
AbbVie USD 740M 40M 2025-06
Amgen USD 653M 32M 2025-12
AstraZeneca USD 484M 181M 2025-12
Bristol-Myers Squibb USD 432M 48M 2025-12
Cipla INR 140.3M 8.5M 2025-12
Compugen USD 954K 116K 2025-09
CSL USD 215M 111M 2025-12
Eisai JPY 1.43B 12M 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
Gilead Sciences USD 255M 1000K 2025-12
GlaxoSmithKline GBP 188M 21M 2025-12
Grifols EUR 156.07M 31.46M 2025-09
Incyte USD 582K 10K 2025-12
Infinity Pharmaceuticals USD 45K 0 2023-06
Ionis Pharmaceuticals USD 18M 0 2025-12
J&J USD 18M 290M 2025-09
Novartis USD 281M 8M 2025-09
Pfizer USD 711M 59M 2025-12
Roche Holding CHF 304M 7.5M 2025-06
TG Therapeutics USD 6.53M 187K 2025-12